Your Article Summary
See Latest ArticlesAutoantibodies against epidermal transglutaminase are a sensitive diagnostic marker in patients with dermatitis herpetiformis on a normal or gluten-free diet
Journal of the American Academy of Dermatology, 06/24/09
Rose C et al. - The authors data suggest that antibodies to eTG are the most sensitive serologic marker in treated and untreated patients with DH and confirm the central role of eTG in the pathogenesis of this disease.
Related Articles
Fibrillar IgA deposition in dermatitis herpetiformis - an underreported pattern with potential clinical significance
Journal of Cutaneous Pathology, 11/18/09
Relevance Score: 68%
Eotaxin (CCL11), TARC [thymus and activation-regulated chemokine (CCL17)], MCP-1 (CCL2) and CCR-1, CXCR-1, CXCR-2 expression in dermatitis herpetiformis and bullous pemphigoid
Archives of Medical Science, 11/03/09
Relevance Score: 64%
Prediction of Clinical and Mucosal Severity of Coeliac Disease and Dermatitis Herpetiformis by Quantification of IgA/IgG Serum Antibodies to Tissue Transglutaminase
Journal of Pediatric Gastroenterology and Nutrition, 10/20/09
Relevance Score: 64%
Linear immunoglobulin A bullous dermatosis
Expert Review of Dermatology, 10/14/09
Relevance Score: 64%
Dapsone hypersensitivity syndrome with circulating 190-kDa and 230-kDa autoantibodies
Clinical and Experimental Dermatology, 10/07/09
Relevance Score: 64%
Today in Derm Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
The 5-D itch scale: a new measure of pruritus
British Journal of Dermatology, 12/10/09
A novel human skin chamber model to study wound infection ex vivo
Archives of Dermatological Research, 12/09/09
Disseminated Herpes Zoster Mimicking Rheumatoid Vasculitis in a Rheumatoid Arthritis Patient on Etanercept
Dermatology, 12/08/09
Today in Dermatopathology...keeping you current
Receive free subspecialty "5-minute updates" via email
Idiopathic Chilblains
American Journal of Medicine, 12/10/09
Randomized, Placebo-Controlled Study of a New Botulinum Toxin Type A for Treatment of Glabellar Lines: Efficacy and Safety
Dermatologic Surgery, 12/10/09
Basic fibroblast growth factor stimulates the proliferation of human dermal fibroblasts via the ERK1/2 and JNK pathways
British Journal of Dermatology, 12/10/09